First Patients Enrolled in PROOF-HD Phase 3 Trial Testing Pridopidine
News
The first U.S. patients have been enrolled in PROOF-HD, a Phase 3 clinical trial investigating pridopidine as a treatment for Huntington’s disease, according to developers Prilenia Therapeutics. PROOF-HD (NCT04556656) ... Read more